Unibest
← Back to patent-cliff list

Anagrelide Hydrochloride Hydrate

Tier C — Watch / trade

Anagrelide Hydrochloride Hydrate

Shire Pharmaceuticals
Originator
1997
First approval
-
Expiry (public)
$0.11B ▲
Peak sales
Small molecule
Type

Targets:PDE3

Brand:Anagrelide CR, Thromboreductin, Agrylin, CR anagrelide, Xagrid

Indications (approved):Essential thrombocythaemia, Myeloproliferative neoplasm

Regional status

US
Approved
1997-03-14
EU
Approved
2004-11-15
China
Approved
2024-02-23
Japan
Approved
2014-09-26

Synthetic routes & intermediates5 routes

Originator routes × 1Optimised (non-patent) × 4Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 4 · Total yield /
ANAG-00115258-72-7ANAG-002459-73-4ANAG-00350608-25-8ANAG-004349150-82-9ANAG-00561834-95-5API · Anagrelide Hydrochloride Hydrate
CodeCAS No.Intermediate
ANAG-00115258-72-71-chloro-2-(chloromethyl)-3-nitrobenzene
ANAG-002459-73-4ethyl glycinate
ANAG-00350608-25-8ethyl 2-((2-chloro-6-nitrobenzyl)amino)acetate
ANAG-004349150-82-9ethyl 2-((2-amino-6-chlorobenzyl)amino)acetate
ANAG-00561834-95-56-chloro-3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one
OptimisedRoute 2Steps 7 · Total yield /
ANAG-00687-61-6ANAG-00787-61-6ANAG-0082112-22-3ANAG-00970380-49-3ANAG-010105-36-2ANAG-01185325-11-7ANAG-01270406-92-7ANAG-013—API · Anagrelide Hydrochloride Hydrate
CodeCAS No.Intermediate
ANAG-00687-61-61,2,3-trichlorobenzene
ANAG-00787-61-61,2,3-trichlorobenzene
ANAG-0082112-22-32,3-dichloro-6-nitrobenzonitrile
ANAG-00970380-49-3(2,3-dichloro-6-nitrophenyl)methanamine
ANAG-010105-36-2Availableethyl 2-bromoacetate
ANAG-01185325-11-7ethyl 2-((2,3-dichloro-6-nitrobenzyl)amino)acetate
ANAG-01270406-92-7ethyl 2-((6-amino-2,3-dichlorobenzyl)amino)acetate
ANAG-013-6,7-dichloro-3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one hydrobromide
OptimisedRoute 3Steps 10 · Total yield /
ANAG-01270406-92-7ANAG-014108-42-9ANAG-015302-17-0ANAG-016—ANAG-0176344-05-4ANAG-0181677-47-0ANAG-01920776-60-7ANAG-02070380-51-7ANAG-02185325-13-9ANAG-022—ANAG-02370381-75-8ANAG-02468475-42-3API · Anagrelide Hydrochloride Hydrate
CodeCAS No.Intermediate
ANAG-01270406-92-7ethyl 2-((6-amino-2,3-dichlorobenzyl)amino)acetate
ANAG-014108-42-93-chloroaniline
ANAG-015302-17-02,2,2-trichloroethane-1,1-diol
ANAG-016-(E)-N-(3-chlorophenyl)-3-hydroxyacrylamide
ANAG-0176344-05-44-chloroindoline-2,3-dione
ANAG-0181677-47-04,5-dichloroindoline-2,3-dione
ANAG-01920776-60-76-amino-2,3-dichlorobenzoic acid
ANAG-02070380-51-7(6-amino-2,3-dichlorophenyl)methanol
ANAG-02185325-13-93,4-dichloro-2-(chloromethyl)aniline hydrochloride
ANAG-022-aminomethyl propionate hydrochloride
ANAG-02370381-75-8ethyl 2-(5,6-dichloro-2-imino-1,2-dihydroquinazolin-3(4H)-yl)acetate hydrobromide
ANAG-02468475-42-36,7-dichloro-3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one
OptimisedRoute 4Steps 5 · Total yield /
ANAG-01185325-11-7ANAG-01270406-92-7ANAG-022—ANAG-02370381-75-8ANAG-0256334-18-5ANAG-02675618-41-6API · Anagrelide Hydrochloride Hydrate
CodeCAS No.Intermediate
ANAG-01185325-11-7ethyl 2-((2,3-dichloro-6-nitrobenzyl)amino)acetate
ANAG-01270406-92-7ethyl 2-((6-amino-2,3-dichlorobenzyl)amino)acetate
ANAG-022-aminomethyl propionate hydrochloride
ANAG-02370381-75-8ethyl 2-(5,6-dichloro-2-imino-1,2-dihydroquinazolin-3(4H)-yl)acetate hydrobromide
ANAG-0256334-18-52,3-dichlorobenzaldehyde
ANAG-02675618-41-62,3-dichloro-6-nitrobenzaldehyde
OptimisedRoute 5Steps 6 · Total yield 59.48 g
ANAG-01270406-92-7ANAG-022—ANAG-02750-45-3ANAG-02838594-42-2ANAG-029393078-37-0ANAG-030192124-88-2ANAG-03170380-50-6API · Anagrelide Hydrochloride Hydrate
CodeCAS No.Intermediate
ANAG-01270406-92-7ethyl 2-((6-amino-2,3-dichlorobenzyl)amino)acetate
ANAG-022-aminomethyl propionate hydrochloride
ANAG-02750-45-32,3-dichlorobenzoic acid
ANAG-02838594-42-2(2,3-dichlorophenyl)methanol
ANAG-029393078-37-0(2,3-dichloro-6-nitrophenyl)methanol
ANAG-030192124-88-21,2-dichloro-3-(chloromethyl)-4-nitrobenzene
ANAG-03170380-50-6ethyl 2-((2,3-dichloro-6-nitrobenzyl)amino)acetate hydrochloride

Frequently asked questions

What are the approved indications of Anagrelide Hydrochloride Hydrate?

Approved indications include: Essential thrombocythaemia, Myeloproliferative neoplasm.

When does the Anagrelide Hydrochloride Hydrate patent expire?

No public expiry year is available for Anagrelide Hydrochloride Hydrate yet; this page updates once verified.

How many synthesis routes are recorded for Anagrelide Hydrochloride Hydrate?

5 synthesis routes are recorded; the shortest is 4 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Anagrelide Hydrochloride Hydrate intermediates?

1 intermediate CAS of Anagrelide Hydrochloride Hydrate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Anagrelide Hydrochloride Hydrate intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29